Results 21 to 30 of about 70,616 (253)
Bronchiectasis is a final common pathway of a wide variety of underlying conditions including infectious, autoimmune, allergic, genetic and inflammatory conditions. Patients experience a chronic disease with variable clinical symptoms and course, but most experience cough, sputum production and recurrent exacerbations.
Miguel Barbosa, James D. Chalmers
openaire +3 more sources
Pseudomonas aeruginosa and lung function decline in patients with bronchiectasis
The objective of this study was to analyse lung function decline over time in bronchiectasis, along with the factors associated with it. Spirometry was measured every year in this observational, prospective study in 849 patients from the Spanish ...
Posadas, T +26 more
core +2 more sources
Clinical features of patients with asthma, bronchiectasis, and combination of both conditions
Background: Asthma and bronchiectasis are critical diseases for public health. In some patients, asthma and bronchiectasis exist together, and bronchiectasis negatively affects asthma control.
Fatih Uzer, Zehra Boztepe, Aykut Cilli
doaj +1 more source
Pathophysiology of Bronchiectasis [PDF]
AbstractBronchiectasis is a complex, heterogeneous disorder defined by both a radiological abnormality of permanent bronchial dilatation and a clinical syndrome. There are multiple underlying causes including severe infections, mycobacterial disease, autoimmune conditions, hypersensitivity disorders, and genetic conditions.
Keir, Holly R., Chalmers, James D.
openaire +3 more sources
Non-antimicrobial airway management of non-cystic fibrosis bronchiectasis
Bronchiectasis are often encountered in clinical practice, and are characterized by abnormal airway dilatation and distortion associated with impaired mucociliary clearance and mucous plugging, which are frequently associated with recurrent infections ...
Ashley M. Egan +2 more
doaj +1 more source
Polymicrobial airway bacterial communities in adult bronchiectasis patients [PDF]
Background: Chronic airway infection contributes to the underlying pathogenesis of non-cystic fibrosis bronchiectasis (NCFBr). In contrast to other chronic airway infections, associated with COPD and CF bronchiectasis, where polymicrobial communities ...
Christopher J Stewart +22 more
core +1 more source
Atorvastatin as a stable treatment in bronchiectasis:a randomised controlled trial [PDF]
Background: Bronchiectasis is characterised by chronic cough, sputum production, and recurrent chest infections. Pathogenesis is poorly understood, but excess neutrophilic airway inflammation is seen.
John W Govan +27 more
core +1 more source
Background Tuberculosis (TB) is considered one of the most common causes of bronchiectasis. Bronchiectasis increases clinical and financial burden of patients with TB.
Maiada K. Hashem +3 more
doaj +1 more source
The frequency of diagnosing bronchiectasis is increasing around the world. Cystic fibrosis is the most common inherited cause of bronchiectasis, but there is increasing recognition of significant numbers of patients with bronchiectasis from various causes.
Kim, Changhwan, Kim, Dong-Gyu
openaire +2 more sources
There are not many articles about the chronic bronchial infection/colonization in patients with underlying lung disease other than cystic fibrosis (CF), especially with non-CF bronchiectasis (NCFBQ). The prevalence of B. cepacia complex is not well known
A. Iglesias +4 more
doaj +1 more source

